Format

Send to

Choose Destination
J Pineal Res. 2015 Mar;58(2):173-7. doi: 10.1111/jpi.12203. Epub 2015 Jan 13.

Melatonin treatment improves primary progressive multiple sclerosis: a case report.

Author information

1
Department of Neurosurgery, Virgen Macarena & Virgen del Rocío University Hospitals, Seville, Spain.

Abstract

We describe the case of a female patient who, at the age of 28, was diagnosed with symptoms of primary progressive multiple sclerosis (PPMS). Glucocorticoid treatment was immediately initiated. The disease and the demyelinating lesions progressed during the following 9 years reaching Expanded Disability Status Scale (EDSS) 8.0 (patient essentially restricted to bed, a chair or perambulated in a wheelchair). At this point, the patient began taking melatonin at doses ranging from 50 to 300 mg per day. Melatonin was her only treatment for the next 4 years; during this interval, her EDSS progressively recovered to 6.0 (the person needs intermittent or unilateral constant assistance such as cane, crutch, or brace to walk 100 meters with or without resting). This long-lasting improvement is likely due to melatonin usage since it is related in time and because of its exceptionally long duration.

KEYWORDS:

melatonin; multiple sclerosis; primary progressive multiple sclerosis

PMID:
25546814
DOI:
10.1111/jpi.12203
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center